| Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma | skin, |
| Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines. | lymphoma,leukemia, |
| NMR assignment of the SH2 domain from the human feline sarcoma oncogene FES. | sarcoma, |
| NMR analysis of Src homology 2 domain from the human feline sarcoma oncogene Fes | sarcoma, |
| Solution structure of the Src homology 2 domain from the human feline sarcoma oncogene Fes. | sarcoma, |
| Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification. | leukemia, |
| Expression of the c-fes proto-oncogene in granulocyte-macrophage colony-stimulating factor-dependent acute myelogenous leukemia cells grown autonomously. | leukemia,colorectal, |
| Expression of the human fes cellular oncogene in renal cell tumors. | kidney, |
| Neosynthesis of neolacto- and novel ganglio-series gangliosides in a rat fibroblastic cell line brought about by transfection with the v-fes oncogene-containing Gardner-Arnstein strain feline sarcoma virus-DNA. | sarcoma, |
| Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis. | None |
| Catalytic assessment of the glycine-rich loop of the v-Fps oncoprotein using site-directed mutagenesis. | None |
| Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts. | None |
| Development and characterization of a panel of monoclonal antibodies against the catalytic domain of the human fes proto-oncogene product. | None |
| Tetranucleotide repeat polymorphism at the human c-fes/fps proto-oncogene (FES). | None |
| The SH2 and catalytic domains of active Fes and Abl pro-oncogenic kinases form integrated structures essential for effective tyrosine kinase signaling. | None |
| Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice. | None |
| The contrasting oncogenic and tumor suppressor roles of FES. | None |
| Expression pattern of c-fes oncogene mRNA in human myeloid cells. | None |
| A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene. | None |
| RFLP of the human c-fes proto-oncogene. | None |